Combination of vitamin E and L-carnitine is superior in protection against isoproterenol-induced cardiac injury: histopathological evidence by Huwait, E.A.
Folia Morphol. 
 Vol. 78, No. 2, pp. 274–282
DOI: 10.5603/FM.a2018.0070 
Copyright © 2019 Via Medica
ISSN 0015–5659 
journals.viamedica.pl
O R I G I N A L    A R T I C L E
274
Combination of vitamin E and L-carnitine  
is superior in protection against  
isoproterenol-induced cardiac injury:  
histopathological evidence
E.A. Huwait
Department of Biology, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
[Received: 16 April 2018; Accepted: 23 May 2018]
Background: L-carnitine and vitamin E have antioxidant properties. This study 
aimed to assess the effectiveness of L-carnitine, vitamin E and their combination in 
protection against isoproterenol (ISO)-induced biochemical and histopathological 
changes in rat heart.
Materials and methods: Fifty male Wistar rats assigned to five groups; control, 
ISO-treated group (100 mg/kg), ISO + vitamin E-treated group (100 IU/kg), ISO 
+ L-carnitine (100 mg/kg) and ISO + vitamin E + L-carnitine treated group. At the 
end of the experiment, serum cardiac enzyme as well as the cardiac level malondi-
aldehyde (MDA), antioxidant enzymes and inflammatory cytokines interleukin-6, 
tumour necrosis factor alpha (TNF-a) were assessed. Histopathological changes 
in the left ventricle wall were assessed using the light and electron microscopy.
Results: Treating rats with vitamin E and L-carnitine could alleviate ISO-induced 
changes as it significantly reduced the serum level cardiac enzymes, MDA and 
IL-6, TNF-a and improved the antioxidants enzymes (SOD, GSPxase and GSRase). 
Histopathologically, they improved cardiac fibres atrophy, haemorrhages between 
cardiac fibres, lost striations, and disturbed sarcomere structure. The combined ef-
fect of vitamin E and L-carnitine was more superior compared to the other groups.
Conclusions: Combined administration of vitamin E, L-carnitine ameliorated the 
biochemical and histopathological cardiac injury induced by ISO. The effect seemed 
to be mediated through the antioxidant and anti-inflammatory effect of vitamin E, 
L-carnitine. Administration of these two elements is recommended for patient at 
risk for myocardial infarction. (Folia Morphol 2019; 78, 2: 274–282)
Key words: vitamin E, L-carnitine, isoproterenol, heart, histology, 
antioxidant, anti-inflammatory
INTRODUCTION
L-carnitine, L-trimethy l-3-hydroxy ammoni-
obetanoate, is a natural endogenous water soluble 
antioxidant located on the mitochondrial membrane 
and is found in all mammals. It reduces the intra-
cellular buildup of toxic metabolites in ischaemic 
conditions [25]. It was reported that “Carnitine plays 
a pivotal role in myocardial energy metabolism 
through transport of long-chain fatty acyl interme-
diates, across the inner mitochondrial membrane for 
subsequent oxidation, and regulation of carbohydrate 
metabolism by modulation of the intramitochondrial 
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acetyl-CoA:CoA ratio” [26]. As such, it is used in the 
prevention and treatment of oxidative stress and 
related health problems [1]. It exerts its antioxidant 
potential by reducing reactive oxygen species (ROS) 
production and scavenging free radicals [17]. 
 A link was reported between consumption of 
carnitine and cardiovascular diseases [27]. However, 
contradictory data were found regarding beneficial 
effects of L-carnitine. Liepinsh et al. [18] reported 
that long-term decrease in L-carnitine is important 
for the energy metabolism regulation and treatment 
of atherosclerosis and heart diseases. On the other 
hand, Zambrano et al. [35] reported that arterial 
hypertension-related cardiac fibrosis could be inhib-
ited by L-carnitine through modulation of peroxisome 
proliferator activated receptor-g expression.
Vitamin E, a fat soluble vitamin, possesses 
a powerful antioxidant activity [2]. Administration of 
vitamin E was found to decrease the cardiovascular 
events in diabetic patients [20]. Contradictory data 
were found in literature regarding the role of vitamin E 
 in protection against cardiac disease. Hu et al. [13] 
found that vitamin E exerted harmful effect in young 
female mice, as it increased cardiomyocyte apoptosis 
after induction of myocardial infarction (MI) while it 
is protective in aged male mice.
Myocardial infarction is an ischaemia-induced 
cardiac muscle necrosis which results from “imbal-
ance between coronary blood supply and myocardial 
demand” [32]. MI induced using isoproterenol was 
adequately reproduced by many researchers [11]. It 
was used to test therapeutic or cardioprotective ef-
fect of any new medication or adjuvant natural sup-
plementation [7]. Therefore, this study was designed 
to evaluate the effectiveness of L-carnitine, vitamin E 
and a combination of both in protection against 
isoproterenol-induced biochemical histopathological 
changes in rat heart.
MATERIALS AND METHODS
Ethical approval
This study was conducted after obtaining the 
ethical approval of the Biomedical Research Ethics 
Committee, Faculty of Medicine, King Abdulaziz Uni-
versity, Jeddah Saudi Arabia and was done at the 
King Fahad Medical Research Centre (KFMRC), King 
Abdulaziz University.
Drug
Isoproterenol hydrochloride was obtained from 
Sigma chemical company, St. Louis, MO, USA. Vitamin E 
 and L-carnitine were obtained from GNC Store at 
Jeddah, Saudi Arabia.
Animals
Fifty male Westar albino rats weighing from 150 
to 200 g and were purchased from the experiment 
animal unit at the KFMRC. They were kept in large 
cages at 25°C with a 12-h dark/light cycle with free 
mobility and allowed free access to water and stand-
ard rat diet ad libitum. They were left to acclimatise 
for 2 weeks in their cages before start the experiment. 
Experimental protocols
Rats were randomly assigned to five groups (n = 10). 
— Group I — served as a control group. Rats of this 
group were injected subcutaneously with 2 mL of 
saline daily for 4 weeks;
— Group II — in which rats were subcutaneously in-
jected with isoproterenol (100 mg/kg body weight 
(BW) in 2 mL of saline daily for 3 successive days 
according to Panda and Kar [23];
— Group III — in which rats were subcutaneously 
injected with isoproterenol with same dose and 
duration plus vitamin E (100 IU/kg BW) intraperi-
toneal injection daily for 4 weeks according to 
Gayathri et al. [8];
— Group IV — in which rats were subcutaneously 
injected with isoproterenol plus intraperitoneal 
daily injection of L-carnitine (100 mg/kg BW) for 
4 weeks according to Wong et al. [33];
— Group V — in which rats were subcutaneously 
injected with isoproterenol plus vitamin E and 
L-carnitine at the same dose for 4 weeks.
Biochemical assessment
At the end of the experiment, blood sample was 
collected from the retro-orbital vein under after thio-
pental anaesthesia. Blood was centrifuged at 4000 g 
at 4°C for 15 min and the serum was stored at –80°C 
till the time of the biochemical assessment of serum 
aspartate transaminase (AST), lactate dehydrogenase 
(LDH), and creatine kinase (CK-MB) by colorimetric 
method using commercial KIT from Biomedical [30]. 
Rats were then sacrificed with cervical dislocation, 
the chest was open and the heart was immediately 
dissected out. 
Part of the heart wall was homogenised in 9 vol-
umes of ice-cold saline and centrifuged at 8000 g at 
4°C for 20 min. Malondialdehyde (MDA) level was as-
sessed in the homogenate as was described according 
to Moran [21]. Superoxide dismutase (SOD) activity 
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was assessed in the homogenate by the nitro blue 
tetrazolium reduction method according to Habig 
et al. [12]. Glutathione peroxidase (GSPxase) was 
assessed as described by Pagila and Valentine [22] 
and glutathione reductase (GSRase) was estimated 
according to Deore et al. [6]. Levels of inflammatory 
cytokines interleukin 6 (IL-6), tumour necrosis fac-
tor alpha (TNF-a) were measured by ELISA kits from 
BIORAD (England).
Histopathological assessment
The dissected heart was washed with saline solu-
tion, cut transversely and longitudinally and fixed 
in 10% buffered neutral formalin solution, and pro-
cessed for obtaining paraffin blocks. These blocks 
were sectioned serially at 4–6 µ and routinely stained 
with haematoxylin and eosin (H&E) [3].
Specimens measured about 2 × 2 mm from left 
ventricle were fixed in 3% glutaraldehyde in phos-
phate buffer at pH 7.4 for 24 h, and post-fixed in 
1% osmic acid for 1 h and further processed to be 
examined with transmission electron microscopy 
(TEM) (JEM-100 Cx11; Jeol) at Assuit University, As-
suit, Egypt. In order to determine the orientation of 
the ultrathin sections, semithin ones with thickness 
1 mm were prepared and stained using toluidine blue 
to be examined by the light microscope. The ultrathin 
sections (prepared at the thickness of 500–800 Å) 
were stained with uranyl acetate and lead citrate.  
RESULTS
Biochemical findings
In this study, rats that received isoproterenol (ISO) 
showed a significant increase in the serum level of 
cardiac enzymes including AST, LDH and CK-MB com-
pared to the control rats. Treating rats with vitamin E, 
L-carnitine or both along with ISO resulted in a sig-
nificant reduction in these enzymes levels compared 
to the untreated rats. However, the level of these 
enzymes did not reach that of the control group. The 
combined effect of both vitamin E and L-carnitine was 
more significant on the level of CK-MB compared with 
LDH and AST (Fig. 1A). The level of MDA, a marker of 
oxidative stress, was assessed in the cardiac tissue ho-
mogenate. It was observed that ISO significantly ele-
vated MDA level in the cardiac homogenate compared 
to the control group. Administration of vitamin E, 
L-carnitine or both along with ISO significantly de-
creased in MDA in the cardiac tissue compared to 
the untreated group (Fig. 1B). 
The levels of SOD, GSPxase and GSRase, the car-
diac antioxidant enzymes, were assessed in the ho-
mogenate of the cardiac tissue. It was observed that 
administration of ISO induced a significant increase in 
the level of SOD and a significant decrease in the level 
of GSPxase and GSRase compared with the control 
group. Administration of vitamin E, L-carnitine or both 
along with ISO significantly reduce the level of SOD 
and significantly increased the levels of GSPxase and 
GSRase when compared with the untreated group. 
Although none of these antioxidants reached the 
level observed in the control group, the combined 
effect of both vitamin E and L-carnitine was more 
significant on the level of GSRase compared with 
other enzymes (Fig. 1C). When it came to the levels 
of the inflammatory cytokines, it was found that the 
levels of IL-6 and TNF-a showed a significant increase 
in the cardiac tissue after administration of ISO while 
their levels were significantly reduced in rats receiving 
both vitamin E and L-carnitine, compared with the 
untreated rats (Fig. 1D, E). 
Histopathological results
Light microscopic findings. The light microscopic 
inspection of the left ventricle of the control rat re-
vealed intact cylindrical cardiac muscle fibres, with 
acidophilic cytoplasm and ill-defined transverse stria-
tions. The nuclei of the cardiac fibres were vesicular, 
oval or rounded and central in position. Connective 
tissue between the fibres was scanty and contained 
thin wall blood capillaries and few fibroblasts identi-
fied by their flat nuclei. The blood vessels, which were 
branches of the coronary vessels between the cardiac 
muscle fibres, had intact wall with normal structure 
and perivascular tissue (Fig. 2A, B).
Isoproterenol administration induced histological 
alterations including atrophy of some cardiac fibres and 
degeneration of some fibres, which was recognised by 
the dark cytoplasm and small pyknotic nuclei. Some 
capillaries appeared congested or ruptured, resulting 
in haemorrhagic foci between the fibres. The blood 
vessels between the fibres appeared damaged with 
perivascular inflammatory cells around them (Fig. 2C, D). 
Sections in the heart wall of groups treated with 
vitamin E, L-carnitine or their combination showed that 
most of the cardiac muscle were intact while few fibres 
were degenerated and the blood vessels appeared nor-
mal similar to control (Fig. 2E, J). 
Semithin sections prepared from the same sam-
ples confirmed what was observed by routine histo-
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Figure 1. Changes in cardiac enzyme (lactate dehydrogenase [LDH], aspartate transaminase [AST], creatine kinase [CK-MB]) (A), malondial-
dehyde (MDA) (B), antioxidant (C), tumour necrosis factor alpha (TNF-a) and interleukin 6 (IL-6) levels (D) in the studied groups; GI — control 
group; GII — isoproterenol group; GIII — isoproterenol + vitamin E group, GIV — isoproterenol + L-carnitine group; GV — isoproterenol 
+ vitamin E + L-carnitine group; GSPxase — glutathione peroxidase; GSRase — glutathione reductase; SOD — superoxide dismutase.
Figure 2. Transverse (A) and longitudinal (B) sections in control rat heart (GI) showed intact cardiac muscle fibres (black arrow) and intact 
blood vessels (white arrow). Sections in heart of GII rats (C, D) show atrophy and decreased size of cardiac fibres (thick arrows) with some 
haemorrhages in between them (asterisk). Some muscle fibres appear degenerated with dark cytoplasm and small pyknotic nuclei (inter-
rupted arrow). The blood vessel (white arrow) appears damaged with perivascular inflammatory cells around. Sections in the heart of GIII rats 
(E, F) and those of GIV rats (G, H) showing few degenerated muscle fibres (interrupted arrows) and the blood vessels appear intact. Sections 
in the heart of GV rats (I, J) showing almost intact muscle fibres and blood vessels (H&E, ×400); GI — control group; GII — isoproterenol 
group; GIII — isoproterenol + vitamin E group, GIV — isoproterenol + L-carnitine group; GV — isoproterenol + vitamin E + L-carnitine 
group; LS — longitudinal section; TS — transverse section.
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logical stains. The cardiac muscle fibres of the control 
rats appeared intact with preserved striation and 
intact capillaries in between. Evident focal damage 
of cardiac fibres was observed in rats receiving ISO 
as some fibres lost their striation compared to the 
control. Most of blood capillaries were dilated and 
congested. On the other hand, most of the cardiac 
muscle fibres in the hearts of the treated groups 
showed preserved striations while few fibres had lost 
them. The rats receiving both vitamin E and L-carnitine 
showed the best effect on preserving the structure 
of the cardiac muscle (Fig. 3).
 Electron microscopic findings. When the ultras-
tructure of the cardiac muscle fibres was assessed us-
ing TEM, it was noticed that the control rats showed 
euchromatic nuclei, intact, well-defined sarcomeres 
and intact mitochondria with normal size and shape. 
On the other hand, cardiac fibres of rats receiving 
ISO appeared atrophied with occasional ill-defined 
sarcomeres, smaller mitochondria with disrupted 
cristae. Although the cardiac fibres of rats treated 
with vitamin E, L-carnitine or a combination of both 
possessed preserved sarcomeres, the mitochondria 
still appeared smaller in size and less frequently seen 
in the fibres compared to the control rats (Figs. 4, 5).
DISCUSSION
“Myocardial infarction is a condition that results 
from the interruption of coronary blood supply 
needed to satisfy myocardial demand, leading to 
Figure 3. Semithin sections in the heart of GI (A) showing intact cardiac muscle fibres with vesicular central nuclei (arrows) and intact stria-
tion. Note, the presence of thin-walled capillaries (white arrow). Section in the heart of GII (B) showing reduced diameter of muscle fibres; 
some of these fibres have dark small nuclei (thick arrow) and some  lost their striations (asterisk). Note that most of blood capillaries are 
dilated and congested (white arrow). Sections in hearts of GIII (C), GIV (D) and GV (E) show that most of muscle fibres are intact with vesicu-
lar nuclei (arrow). Striations are preserved in most of the muscle fibres while few lost them (toluidine blue stain, ×600); GI — control group; 
GII — isoproterenol group; GIII — isoproterenol + vitamin E group, GIV — isoproterenol + L-carnitine group; GV — isoproterenol + vitamin E 
+ L-carnitine group.
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oxygen and nutrient deprivation of the heart, even-
tually destroying cardiac tissues” [5]. “Isoproterenol, 
a synthetic catecholamine and adrenergic agonist 
that is documented to produce in large dose due to 
generation of highly cytotoxic free radicals through 
its auto-oxidation”. These free radicals initiate lipid 
peroxidation and induce irreversible damage of the 
myocardial membrane [9]. This study was planned 
to assess the possible protective effect of vitamin E, 
L-carnitine, and a combination of both on ISO-in-
duced changes in rat cardiac muscle.
The diagnostic cardiac enzymes CK-MB, LDH and 
AST are considered sensitive markers that are used 
to assess the severity of MI [32]. In this study, ISO 
significantly increased the levels of diagnostic cardiac 
enzymes (LDH, AST and CK-MB) in the serum and MDA 
level in the cardiac tissue compared with the control 
rats. In addition, it significantly increased SOD activity 
and significantly decreased GSPxase and GSRase activ-
ity indicating its harmful effect on the cardiac muscle. 
These findings were supported by those of Panda et 
al. [24] observed in rats after administration of ISO. 
Free radicals generated by ISO stimulate lipid 
peroxidation of polyunsaturated fatty acid of the 
membrane, with subsequent loss of the structure and 
function of the myocardium. When the metabolic 
function of the myocardium is disturbed, it releases 
its lysosomal enzymes into the blood. Therefore, the 
serum levels of AST, LDH and CK-MB were found to 
be significantly increased [19].
Isoproterenol induced structural alterations in car-
diac muscle. Among these alternations were the ap-
pearance of some muscle fibres with dark cytoplasm 
and small pyknotic nuclei, indicating apoptosis and 
Figure 4. Electron microscope micrograph of rat cardiac muscle from the left ventricle of control group (GI) (A, B) showing normal structure 
of the cardiac fibres with open face nuclei (N), well defined sarcomeres (black arrows) and normal size and site of mitochondria (thick white 
arrows). Cardiac muscle of isoproterenol-treated group (GII) (C, D) showing reduced diameter (atrophy) of cardiac muscles (interrupted 
arrow) with occasional ill-defined sarcomeres (arrows). Mitochondria appear smaller in size with disrupted cristae (thick white arrows). 
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degeneration of these fibres. These finding was sup-
ported by those previous reported by Shukla et al. [28] 
who stated that ISO initiates apoptosis evidenced by 
up-regulation of TUNEL and Bax expression and down 
regulation of Bcl-2 expression. Atrophy of cardiac 
muscle fibres as well as haemorrhage and conges-
tion of some blood vessel were observed following 
ISO administration in this study. These finding were 
in agreement with what was reported by Panda et 
al. [24] following administration of ISO. Gayathri et 
al. [8] reported that ISO administration was associ-
ated with vascular changes, oedema and leucocyte 
infiltration. Marked focal myonecrosis where among 
the histopathological changes induced by ISO in 
rats as described by Shukla et al. [28]. In this study, 
ISO administration affected also the sarcomere, the 
functional unit of muscle fibre, and mitochondria, 
which are the powerhouses of the fibre. Damage 
to membranous organelles, such as mitochondria, 
is attributed to lipid peroxidation induced by ISO 
[10]. Tappia et al. [29] reported that “oxidative stress 
increases cAMP levels by exhausting ATP, depresses 
Figure 5. Electron microscope micrograph of rat cardiac muscle from the left ventricle of isoproterenol + vitamin E group (GIII) (A, B), isopro-
terenol + L-carnitine group (GIV) (C, D) and isoproterenol + vitamin E + L-carnitine group (GV) (E, F) showing increased diameter of most 
of the cardiac fibres, defined sarcomeres (black arrows) while the mitochondria (thick white arrows) still have small size and fewer number 
compared to the control group. 
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sarcolemmal Ca2+ transport resulting in intracellular 
calcium overload, leading to ventricular dysfunction 
and contractile failure in rat heart”. 
In the present study, administration of L-carnitine 
was found to protect rat heart from ISO-induced 
changes observed in untreated group. It improved the 
oxidative stress induced by ISO as evidenced by the 
significant reduction in MDA. In addition, L-carnitine 
increased antioxidant capacity of the cardiac muscle 
evidenced by increased GSPxase and GSRase activity. 
In another model of MI induced by amethopterin, 
L-carnitine was found to improve the biochemical, 
histopathological, and immunohistochemical alter-
ations followed amethopterin administration [31]. 
Previously L-carnitine administration was reported 
to have a cardioprotective role in cardiomyopathy 
and prevention of MI [14]. Lee et al. [15] found that 
L-carnitine supplementation increased antioxidant 
enzymes, improved lipid profile and decreased oxida-
tive stress in patients with coronary artery diseases.
Vitamin E in the present study was also found to 
ameliorate degenerative changes and other cardiac 
fibre alterations induced by ISO administration. This 
protection was observed at both light and electron 
microscopic level. In addition, vitamin E reduced ISO-
-induced oxidative stress as evidenced by reduction 
in MDA. Vitamin E also increased cardiac muscle 
antioxidant capacity evidenced by increased GSPxase 
and GSRase activity. The anti-inflammatory effect of 
vitamin E was evident as it significantly reduced the 
elevated inflammatory cytokines IL-6 and TNF-a in the 
cardiac tissue after administration of ISO. These find-
ing were supported by the study of Boaz et al. [4] and 
Lee et al. [16], who stated that vitamin E was known 
to be a potent antioxidant with proven effectiveness 
in prevention of cardiovascular diseases. It has been 
proposed that the cardio protective effect of L-car-
nitine and vitamin E is due to anti-inflammatory and 
antioxidant activities on coronary endothelial function 
and vasoreactivity [34]. This could explain the better 
effect induced by the combination of L-carnitine and 
vitamin E in protection against ISO-induced cardiac 
injury that was documented in this study.
Among the limitations of this study was the in-
ability to assess changes in gene expression of the 
antioxidant profile in the cardiac muscle in all stud-
ied groups in order to prove the mechanism behind 
the augmentation of action between vitamin E and 
L-carnitine.
CONCLUSIONS  
AND CLINICAL IMPLICATIONS
This biochemical and histological studies dem-
onstrated that administration of vitamin E and 
L-carnitine ameliorated cardiac alteration induced 
by ISO with the superior effect of the combination 
of both agents. Based on these findings it is likely 
that administration of these two elements is rec-
ommended for patient at risk of MI as they exert 
a cardio protective effect by stabilizing the myocardial 
membrane. The membrane-stabilising activity may 
be due to an increase in endogenous antioxidants, 
which may increase the myocardial antioxidant re-
serve and strengthen the defence mechanism(s) in 
the myocardium.
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